KINTARA THERAPEUTICS

kintara-therapeutics-logo

Kintara Therapeutics is a developer of novel cancer therapies for patients with unmet medical needs.

#SimilarOrganizations #People #Website #More

KINTARA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.kintara.com

Total Employee:
1+

Status:
Active

Contact:
858-350-4364

Total Funding:
33.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache Global Site Tag


Similar Organizations

pregenen-logo

Pregenen

Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.


Current Advisors List

saiid-zarabian_image

Saiid Zarabian CEO @ Kintara Therapeutics
Board_member

Current Employees Featured

dennis-m-brown_image

Dennis M. Brown
Dennis M. Brown Co-Founder & Chief Scientific Officer @ Kintara Therapeutics
Co-Founder & Chief Scientific Officer
2020-08-01

not_available_image

Jeffrey A. Bacha
Jeffrey A. Bacha Founder @ Kintara Therapeutics
Founder

not_available_image

Jeffrey A. Bacha
Jeffrey A. Bacha Founder @ Kintara Therapeutics
Founder

Founder


dennis-m-brown_image

Dennis M. Brown

not_available_image

Jeffrey A. Bacha

Stock Details


Company's stock symbol is NASDAQ:KTRA

Official Site Inspections

http://www.kintara.com

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Kintara Therapeutics"

Corporate Governance :: Kintara Therapeutics, Inc. (KTRA)

In 2008 and 2010, she was honored as a biotechnology entrepreneur by the national organization, Women in Bio, and in 2008 received the Rising Star Award by the Wisconsin Biotech and โ€ฆSee details»

Investors :: Kintara Therapeutics, Inc. (KTRA)

Oct 14, 2024 Kintara Therapeutics, Inc. 9920 Pacific Heights Blvd, Suite 150 San Diego, CA 92121 United States T: 858-350-4364 [email protected]. Investor Relations. T: 858-350-4364 [email protected]. Transfer Agent. Mountain Share โ€ฆSee details»

Management Team :: Kintara Therapeutics, Inc. (KTRA)

Mr. Hoffman formerly served as a director and President of the San Diego Chapter of Financial Executives International and was an advisor to the Financial Accounting Standard Board โ€ฆSee details»

Kintara Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

View Kintara Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Kintara Therapeutics Company Profile | Management and

Kintara Therapeutics Profile and History. Founded in 2009, Kintara Therapeutics is a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies โ€ฆSee details»

Kintara Therapeutics Provides Update on Corporate Developments โ€ฆ

Sep 11, 2024 Information about Kintara's directors and executive officers is available in Kintara's proxy statement, which was filed with the SEC on May 17, 2024 for the 2024 Annual Meeting โ€ฆSee details»

Kintara Therapeutics, Inc. NASDAQ: KTRA | LinkedIn

Kintara Therapeutics, Inc. NASDAQ: KTRA | 1,014 followers on LinkedIn. Seeking New Horizons for Cancer Patients | Our Fight Against Cancer Kintara Therapeutics is dedicated to the โ€ฆSee details»

Kintara Therapeutics Provides Update on Corporate Developments โ€ฆ

Sep 11, 2024 Kintara's existing stockholders will own approximately 5.45% of combined company's common stock at the closing of the proposed Merger on a pro forma fully diluted โ€ฆSee details»

Kintara Therapeutics - Crunchbase Company Profile

Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The companyโ€™s principal product โ€ฆSee details»

Kintara Therapeutics, Inc. | European Clinical Trials Information โ€ฆ

Kintara Therapeutics, Inc. is a biopharmaceutical company that specializes in the development of innovative cancer therapies. The company was founded in 2013 and is headquartered in San โ€ฆSee details»

Kintara Therapeutics Company Profile 2024: Valuation, Investors ...

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready โ€ฆSee details»

Board Committees :: Kintara Therapeutics, Inc. (KTRA)

In addition, Ms. Johnson has served as a member of the board of directors of Harmony Hill Farm Sanctuary since 2019. In 2008 and 2010, she was honored as a biotechnology entrepreneur โ€ฆSee details»

TuHURA Biosciences Completes Merger Transaction with Kintara ...

Oct 17, 2024 As a result of the merger, post-merger Kintara equityholders collectively own approximately 2.85% (or approximately 5.45% after giving effect to the shares issued pursuant โ€ฆSee details»

Kintara Announces Changes to Executive Leadership Team - PR โ€ฆ

Nov 9, 2021 About Kintara. Located in San Diego, California, Kintara (Nasdaq: KTRA) is dedicated to the development of novel cancer therapies for patients with rare unmet medical โ€ฆSee details»

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive ...

Apr 3, 2024 About the Proposed Transaction, Management & Organization. Under the terms of the merger agreement, subject to stockholder approval, on a pro forma basis, post-merger โ€ฆSee details»

Kintara Therapeutics Announces Fiscal 2024 Third Quarter โ€ฆ

SAN DIEGO, May 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of โ€ฆSee details»

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results โ€ฆ

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of โ€ฆSee details»

Kintara Therapeutics Announces Fiscal 2024 Financial Results and ...

Jun 30, 2023 At Kintara's special meeting of stockholders held on October 4, 2024, Kintara's stockholders approved the requisite proposals to effect the completion of the proposed Merger โ€ฆSee details»

Kintara Therapeutics, Inc. (KTRA) - Yahoo Finance

Kintara Therapeutics, Inc. (KTRA) - Yahoo FinanceSee details»

linkstock.net © 2022. All rights reserved